141
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Focusing solely on the effect of the medication without taking a holistic view of the patient does not seem very constructive

Comment on “Baclofen and the ‘first do not harm’ motto: a new French paradox?”

, &
Page 309 | Received 16 Aug 2017, Accepted 26 Aug 2017, Published online: 05 Sep 2017

References

  • Braillon A, Naudet F. Baclofen and the “first do not harm” motto: a new French paradox? Clin Toxicol. 2017. [Epub ahead of print]. doi: 10.1080/15563650.2017.1366501
  • Rolland B, Paille F, Fleury B, et al. Off-label baclofen prescribing practices among French alcohol specialists: results of a national online survey. PLoS One. 2014;9:e98062.
  • Baldwin DS, Tiwari N, Gordon R. Sense and sensibility when prescribing ‘off-label’ to psychiatric patients. Curr Pharm Des. 2015;21:3276–3279.
  • Rolland B, Paille F, Gillet C, et al. Pharmacotherapy for alcohol dependence: the 2015 recommendations of the French Alcohol Society, issued in partnership with the European Federation of Addiction Societies. CNS Neurosci Ther. 2016;22:25–37.
  • Reynaud M, Aubin HJ, Trinquet F, et al. A randomized, placebo-controlled study of high-dose baclofen in alcohol-dependent patients – the ALPADIR study. Alcohol Alcohol. 2017;52:439–446.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.